159 related articles for article (PubMed ID: 38635030)
21. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
22. HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial protocol.
Mathier E; Althaus A; Zwahlen D; Lustenberger J; Zamboglou C; De Bari B; Aebersold DM; Guckenberger M; Zilli T; Shelan M
BMJ Open; 2024 Jan; 14(1):e075846. PubMed ID: 38296279
[TBL] [Abstract][Full Text] [Related]
23. Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.
Sridhar AN; Cathcart PJ; Yap T; Hines J; Nathan S; Briggs TP; Kelly JD; Minhas S
J Sex Med; 2016 Mar; 13(3):435-43. PubMed ID: 26944466
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy.
Oehus AK; Kroeze SGC; Schmidt-Hegemann NS; Vogel MME; Kirste S; Becker J; Burger IA; Derlin T; Bartenstein P; Eiber M; Mix M; la Fougère C; Belka C; Combs SE; Grosu AL; Müller AC; Guckenberger M; Christiansen H; Henkenberens C
BMC Cancer; 2020 Apr; 20(1):362. PubMed ID: 32349700
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the Oncological and Functional Outcomes of Brachytherapy and Radical Prostatectomy for Localized Prostate Cancer.
Wang F; Luan Y; Fan Y; Huang T; Zhu L; Lu S; Tao H; Sheng T; Chen D; Ding X
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295548
[No Abstract] [Full Text] [Related]
26. Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.
Qaoud Y; Herrera-Caceres JO; Bass R; Berjaoui MB; Tiwari R; Kenk M; Lajkosz K; Finelli A; Perlis N; Klotz L; Fleshner N
Urol Oncol; 2022 Jul; 40(7):343.e1-343.e6. PubMed ID: 35537905
[TBL] [Abstract][Full Text] [Related]
27. Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy.
Adam M; Tennstedt P; Lanwehr D; Tilki D; Steuber T; Beyer B; Thederan I; Heinzer H; Haese A; Salomon G; Budäus L; Michl U; Pehrke D; Stattin P; Bernard J; Klaus B; Pompe RS; Petersen C; Huland H; Graefen M; Schwarz R; Huber W; Loeb S; Schlomm T
Eur Urol; 2017 Mar; 71(3):330-336. PubMed ID: 27887941
[TBL] [Abstract][Full Text] [Related]
28. Prospective comprehensive assessment of sexual function after retropubic non nerve sparing radical prostatectomy for localized prostate cancer.
Trinchieri A; Nicola M; Masini F; Mangiarotti B
Arch Ital Urol Androl; 2005 Dec; 77(4):219-23. PubMed ID: 16444937
[TBL] [Abstract][Full Text] [Related]
29. [Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].
Vidmar R; Marcq G; Flamand V; Fantoni JC; Hénon F; Villers A; Ouzzane A
Prog Urol; 2017; 27(8-9):458-466. PubMed ID: 28576424
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy after radical prostatectomy for prostate cancer: clinical outcomes and factors influencing biochemical recurrence.
Fukuda I; Aoki M; Kimura T; Ikeda K
Ir J Med Sci; 2023 Dec; 192(6):2663-2671. PubMed ID: 37097540
[TBL] [Abstract][Full Text] [Related]
31. Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime.
Nyarangi-Dix JN; Steimer J; Bruckner T; Jakobi H; Koerber SA; Hadaschik B; Debus J; Hohenfellner M
World J Urol; 2017 Dec; 35(12):1841-1847. PubMed ID: 28861691
[TBL] [Abstract][Full Text] [Related]
32. Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review.
Calleris G; Marra G; Dalmasso E; Falcone M; Karnes RJ; Morlacco A; Oderda M; Sanchez-Salas R; Soria F; Gontero P
World J Urol; 2019 Aug; 37(8):1469-1483. PubMed ID: 30955047
[TBL] [Abstract][Full Text] [Related]
33. A matter of size? Health-related quality of life after radical prostatectomy for patients with giant prostates.
Westhofen T; Buchner A; Schlenker B; Becker A; Chaloupka M; Bischoff R; Stief CG; Kretschmer A
Prostate; 2021 Jun; 81(8):443-451. PubMed ID: 33878204
[TBL] [Abstract][Full Text] [Related]
34. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
35. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
[TBL] [Abstract][Full Text] [Related]
36. Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments.
Marra G; Calleris G; Massari E; Vissio E; Molinaro L; Cassoni P; D'Agate D; Oderda M; Valerio M; Raskin Y; Joniau S; Papotti M; Gontero P
Eur Urol Open Sci; 2023 Jan; 47():110-118. PubMed ID: 36601045
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients.
Spiotto MT; Hancock SL; King CR
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):54-61. PubMed ID: 17459606
[TBL] [Abstract][Full Text] [Related]
38. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.
King CR; Spiotto MT
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):23-7. PubMed ID: 18207668
[TBL] [Abstract][Full Text] [Related]
39. Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml.
Umezawa R; Ariga H; Ogawa Y; Jingu K; Matsushita H; Takeda K; Fujimoto K; Sakayauchi T; Sugawara T; Kubozono M; Narazaki K; Shimizu E; Takai Y; Yamada S
Radiat Oncol; 2011 Nov; 6():150. PubMed ID: 22053922
[TBL] [Abstract][Full Text] [Related]
40. Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review.
Marra G; Marquis A; Yanagisawa T; Shariat SF; Touijer K; Gontero P
Eur Urol Focus; 2023 Mar; 9(2):251-257. PubMed ID: 36822924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
